Creating materials for testing new influenza vaccines
Official title: Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing
Funded at Idt Biologika Gmbh · NIH-11167540 · Data updated 2026-11-12
This study is working on creating and improving materials for new flu vaccines, which could help keep you and others safer from the flu and similar illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project start | September 26, 2023 |
| Project end | December 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,537,665 |
| NIH project number | 272201800011I-P00001-759302300001-1 |
| Project ID | NIH-11167540 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would include individuals at risk for influenza or those who may require vaccination.
✕Less likely to help
Patients who are not at risk for influenza or those who have contraindications to vaccination may not receive benefit from this research.
What this research studies
This research focuses on the production and characterization of materials needed for clinical testing of influenza vaccines. It involves planning and optimizing vaccine development, ensuring compliance with manufacturing standards, and providing regulatory support for submissions to the FDA. Patients may benefit from the development of new vaccines that could improve protection against influenza and related infectious diseases. The research aims to facilitate the introduction of innovative vaccines and biologics.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective influenza vaccines, enhancing patient protection against the virus.
How similar studies have gone: Other research has shown success in developing vaccines through similar manufacturing and testing approaches, indicating a promising path for this project.
Where this research is happening
-
Idt Biologika Gmbh
Dessau-Rosslau, Germany Active
Researchers
- Principal investigator: Singh, Suneel — Idt Biologika Gmbh
- Study coordinator: Singh, Suneel
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Surveillance and preparedness for flu and other respiratory pathogens in Kenya
A US-based research grant aims to improve how Kenya detects and prepares for influenza and other respiratory diseases to protect people there and global health.
-
Enhanced Seasonal Influenza Vaccine Targeting Shared and Variable Viral Antigens
A new DNA-based influenza vaccine approach aims to provide both precise protection against circulating strains and broader defense against unexpected strains.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.